In vivo biological response following low-dose interleukin-2 in complete remission B-cell non-Hodgkin's lymphoma patients. Italian Lymphoma Study Group (GISL).

Source:http://linkedlifedata.com/resource/pubmed/id/8698128

Download in:

View as

General Info

PMID
8698128